drug-repurposing
7 stories tagged "drug-repurposing"
To Keep Cancer-Fighting Cells Alive, a Sloan Kettering Lab Wants Them to Fight Less Hard
Memorial Sloan Kettering researchers say throttling exhausted T cells with a drug class already used against melanoma may keep them alive longer. So far the evidence comes only from lab and animal models.
CancerA Generic Vitamin D Drug Quadrupled Chemo Responses in a Small Pancreatic Cancer Trial, and Its Phase 2 Never Ran
Forty-two percent of patients on paricalcitol plus chemo saw their tumors shrink, versus 9 percent on placebo, in a 36-person safety trial. The randomized phase 2 meant to follow it never ran.
Drugs & FDANo FDA-Approved Drug Stops Preterm Labor: a Vanderbilt Screen of All 1,191 Approved Drugs Landed on an Asthma Steroid
Every drug used to halt preterm contractions is borrowed off-label; the FDA has never approved one for the job. A Vanderbilt team screened all 1,191 approved drugs and landed on an asthma steroid.
Autoimmune & InflammationA Fat 'Brake' Eased Pain in 49 Men but Barely Touched the Swelling
UCL researchers gave 49 healthy men a drug GlaxoSmithKline shelved after early trials. Pain resolved faster and a class of immune cells shrank, but the heat, redness, and swelling showed no significant change.
CancerUC Irvine's 'Framework' for Safer CAR-T Is a Hypothesis Essay, Not a Study
The senior author consults for Kite Pharma, whose Yescarta accounted for all 6 grade-5 neurotoxicity deaths in the cited review's real-world data, the exact harm the paper proposes to treat.
Drugs & FDAThe FDA Pulled Infigratinib as a Cancer Drug in 2024. It Just Passed Phase 3 in Children With Dwarfism.
The FDA pulled infigratinib as a failed cancer drug in 2024. Now its maker says the same pill grows children with dwarfism faster, on a surrogate no one has yet shown reaches adulthood.
CancerFibrolamellar Carcinoma Hides Immune Cells in Scar Tissue. A Drug Approved in 2008 Pulled Them Back Out.
Fibrolamellar carcinoma mostly kills young adults, and checkpoint immunotherapy bounces off it. Researchers found the tumor herds T cells into fibrous bands, and a drug shelved for stem-cell work since 2008 freed them in patient tissue. No human trial has started.